SG3 Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

SG3 Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,000	Closed	-$1.39M	–	1503
2021 Q4	$1.39M	Sell	15,000 -69,600	-82%	-$4.59M	0.03%	410
2021 Q3	$5.04M	Buy	+84,600	New	+$5M	0.15%	140
2021 Q2	–	Sell	-15,000	Closed	-$1.04M	–	1464
2021 Q1	$1.04M	Buy	15,000 +3,000	+25%	+$231K	0.03%	600
2020 Q4	$922K	Sell	12,000 -57,500	-83%	-$4.31M	0.02%	584
2020 Q3	$5.2M	Buy	+69,500	New	+$4.63M	0.19%	127

SG3 Management's ARNA Position: Q1 2022 in Review

SG3 Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 47,100 shares — an estimated $4.38M sold.

SG3 Management first reported a position in ARNA in Q2 2020 and held it in 2 quarters. The position peaked at $4.38M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

SG3 Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
SG3 Management sold 47,100 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.38M.
SG3 Management first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 2 quarters.
SG3 Management's Arena Pharmaceuticals Inc position peaked at $4.38M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.